Patent assignee · US · COMPANY

Kite Pharma, Inc.

🏢 View company profile →
37Patents
37Active
37Granted
54Portfolio score

Filing activity: May 27, 2016 → Dec 20, 2022

Most-cited patents

PatentTitleAreaCited byStatus
US9855298B2 Methods of conditioning patients for T cell therapy Chemistry; Metallurgy 29 Active
US10603380B2 Chimeric antigen and T cell receptors and methods of use Chemistry; Metallurgy 12 Active
US10626187B2 Antigen binding molecules specific for an anti-CD19 scFv Chemistry; Metallurgy 6 Active
US10844120B2 Humanized antigen-binding domains and methods of use Chemistry; Metallurgy 5 Active
US10501775B2 Antigen binding molecules and methods of use thereof Emerging Cross-Sectional Technologies 5 Active
US10322146B2 Methods of conditioning patients for T cell therapy Chemistry; Metallurgy 4 Active
US10844371B2 Antigen binding molecules and methods of use thereof Chemistry; Metallurgy 3 Active
US10597456B2 Chimeric receptors and methods of use thereof Chemistry; Metallurgy 2 Active
US11384155B2 Antigen binding molecules specific for an anti-CD19 scFv Chemistry; Metallurgy 2 Active
US11608517B2 Antigen binding molecules and methods of use thereof Emerging Cross-Sectional Technologies 1 Active
US11491187B2 Methods of conditioning patients for T cell therapy Chemistry; Metallurgy 1 Active
US11779601B2 Diagnostic methods for T cell therapy Physics 1 Active
US11572388B2 Chimeric polypeptides and uses thereof Chemistry; Metallurgy 1 Active
US11390655B2 Modified chimeric antigen receptors and methods of use Chemistry; Metallurgy 1 Active
US12404305B2 Chimeric polypeptides and uses thereof Chemistry; Metallurgy 0 Active
US12156887B2 Chimeric receptor T cell treatment using characteristics of the tumor microenvironment Physics 0 Active
US11723923B2 Methods of preparing T cells for T cell therapy Chemistry; Metallurgy 0 Active
US11046775B2 CD70 binding molecules and methods of use thereof Chemistry; Metallurgy 0 Active
US11357796B2 Treatment using chimeric receptor T cells incorporating optimized polyfunctional T cells Human Necessities 0 Active
US11129872B2 Methods of making and using soluble MHC molecules Physics 0 Active
US12280119B2 Chimeric transmembrane proteins and uses thereof Chemistry; Metallurgy 0 Active
US12337035B2 TACI binding molecules Chemistry; Metallurgy 0 Active
US12109235B2 TGF-beta receptors and methods of use Human Necessities 0 Active
US12331315B2 Chimeric antigen receptor Chemistry; Metallurgy 0 Active
US11834654B2 Antigen binding molecules and methods of use thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.